Items

Potential Strategies to Limit Inappropriate Purchasing of Antibiotics without a Prescription in a Rural Province in South Africa: Pilot Study and the Implications (2024-01)

T. Milta Sono, M. Maluleka, A. Golić, S. Campbell, V. Marković Peković, N. Schellack, S. Kumar, B. Godman, J. Meyer, Potential Strategies to Limit Inappropriate Purchasing of Antibiotics without a Prescription in a Rural Province in South Africa: Pilot Study and the Implications, Advances in Human Biology, Vol. 1, No. 14, pp. 60 - 67, Jan, 2024
Effective Programmes to Reduce Inappropriate Dispensing of Antibiotics in Community Pharmacies Especially in Developing Countries (2024-01)

T. Milta Sono, B. Godman, V. Marković Peković, Effective Programmes to Reduce Inappropriate Dispensing of Antibiotics in Community Pharmacies Especially in Developing Countries, Advances in Human Biology, Vol. 1, No. 14, pp. 1 - 4, Jan, 2024
Pilot Study to Evaluate the Feasibility of a Patient Questionnaire for the Purpose of Investigating the Extent of Purchasing Antibiotics without a Prescription in a Rural Province in South Africa: Rationale and Implications (2024-03)

T. Milta Sono, M. Maluleka, N. Ramdas, A. Golić, S. Campbell, V. Marković Peković, N. Schellack, S. Kumar, B. Godman, J. Meyer, Pilot Study to Evaluate the Feasibility of a Patient Questionnaire for the Purpose of Investigating the Extent of Purchasing Antibiotics without a Prescription in a Rural Province in South Africa: Rationale and Implications, Advances in Human Biology, Vol. 2, No. 14, pp. 138 - 147, Mar, 2024
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance (2023-04)

T. Milta Sono, E. Yeika, A. Cook, A. Kalungia, S. Opanga, J. Acolatse, I. Sefah, A. Golić, S. Campbell, G. Lorenzetti, Z. Ul Mustafa, V. Marković Peković, A. Kurdi, B. Paramadhas, G. Rwegerera, A. Amu, M. Alabi, E. Wesangula, M. Oluka, F. Khuluza, I. Chikowe, J. Fadare, O. Ogunleye, D. Kibule, E. Hango, N. Schellack, N. Ramdas, A. Massele, S. Mudenda, I. Hoxha, C. Moore, B. Godman, J. Meyer, Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance, Expert Rev Anti Infect Ther, Vol. 21, No. 10, pp. 1025 - 1055, Apr, 2023
Essential to increase the use of generics in Europe to maintain comprehensive health care? (2012-01)

B. Godman, M. Bennie, C. Baumgartel, L. Sović-Brkičić, T. Burkhardt, J. Furst, K. Garuoliene, M. Gomes, V. Marković Peković, A. Martin, C. Sermet, P. Skiold, M. van Woerkom, L. Vončina, L. Gustafsson, Essential to increase the use of generics in Europe to maintain comprehensive health care?, STED Journal, Vol. 13, No. 3S, pp. 5 - 20, Jan, 2012
Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions (2012-09)

V. Marković Peković, R. Škrbić, B. Godman, L. Gustafsson, Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions, Expert Review of Pharmacoeconomics & Outcomes Research , Vol. 12, No. 5, pp. 661 - 671, Sep, 2012
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs (2014-06)

B. Godman, R. Malmstrom, E. Digene, S. Jayathissa, S. McTaggart, T. Cars, S. Alvarez-Madrazo, C. Baumgartel, A. Brzezinska, A. Bucsics, S. Campbell, I. Eriksson, A. Finlayson, J. Furst, K. Garuoliene, I. Gutierrez-Ibarluzea, K. Hviding, H. Herholz, R. Joppi, R. Joppi, M. Kalaba, O. Laius, K. Malinowska, H. Pedersen, V. Marković Peković, J. Piessnegger, G. Selke, C. Sermet, S. Spillane, D. Tomek, L. Vončina, V. Vlahović-Palčevski, J. Wale, M. Wladysiuk, M. van Woerkom, C. Zara, L. Gustafsson, Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs, Frontiers in Pharmacology, Vol. 5, pp. 1 - 11, Jun, 2014
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications (2014-06)

B. Godman, B. Wettermark, M. van Woerkom, J. Fraeyman, S. Alvarez-Madrazo, C. Berg, I. Bishop, A. Bucsics, S. Campbell, A. Finlayson, J. Furst, K. Garuoliene, H. Herholz, M. Kalaba, O. Laius, J. Piessnegger, C. Sermet, U. Schwabe, V. Vlahović-Palčevski, V. Marković Peković, L. Vončina, K. Malinowska, C. Zara, L. Gustafsson, Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications, Frontiers in Pharmacology, Vol. 5, pp. 1 - 9, Jun, 2014
Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future (2015-05)

B. Godman, M. Wilcock, A. Martin, S. Bryson, C. Baumgartel, T. Bochenek, W. de Bruyn, L. Sović-Brkičić, M. D'Agata, A. Fogele, A. Coma Fuste, J. Fraeyman, J. Furst, K. Garuoliene, H. Herholz, M. Hoffman, S. Jayathissa, H. Kwon, I. Langner, M. Kalaba, E. Magnusson, E. Anderse Karlssen, O. Laius, V. Marković Peković, E. Magnusson, S. McTaggart, H. Pedersen, J. Piessnegger, A. Ringerud, G. Selke, C. Sermet, K. Schiffers, P. Skiold, D. Tomek, A. Viksna, A. Vitry, C. Zara, R. Malmstrom, Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future, Generics and Biosimilars Initiative Journal, Vol. 4, No. 3, pp. 125 - 135, May, 2015
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways (2016-09)

M. Ermisch, A. Bucsics, P. Vella Bonanno, F. Arickx, A. Bybau, T. Bochenek, M. van der Casteele, E. Digene, J. Furst, K. Garuoliene, M. van der Graff, J. Gulbinovic, A. Haycox, J. Jones, R. Joppi, O. Laius, I. Langner, A. Martin, V. Marković Peković, L. McCullagh, E. Magnusson, E. Nilsen, G. Selke, C. Sermet, S. Simoens, R. Sauremann, A. Schuurman, R. Ramos, V. Vlahović-Palčevski, C. Zara, B. Godman, Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways, Frontiers in Pharmacology, Vol. 7, pp. 1 - 9, Sep, 2016
Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future (2016-10)

V. Marković Peković, R. Škrbić, A. Petrović, V. Vlahović-Palčevski, J. Mrak, M. Bennie, J. Fadare, H. Kwon, K. Schiffers, I. Truter, B. Godman, Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future, Expert Review of Pharmacoeconomics & Outcomes Research , Vol. 16, No. 5, pp. 609 - 618, Oct, 2016
Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications (2017-06)

V. Marković Peković, N. Grubiša, J. Burger, L. Bojanić, B. Godman, Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications, Journal of Research in Pharmacy Practice, Vol. 6, pp. 120 - 125, Jun, 2017
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications (2017-08)

A. Ferrario, D. Araja, T. Bochenek, T. Ćatić, D. Danko, M. Dimitrova, J. Furst, I. Greičiute-Kuprijanov, I. Hoxha, A. Jakupi, E. Laidmae, O. Loblova, I. Mardare, V. Marković Peković, D. Meshkov, T. Novakovic, G. Petrova, M. Pomorski, D. Tomek, L. Vončina, A. Haycox, P. Kanavos, P. Vella Bonanno, B. Godman, The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications, PHARMACOECONOMICS, pp. 1 - 15, Aug, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation (2017-08)

P. Vella Bonanno, M. Ermisch, B. Godman, A. Martin, J. Van Den Bergh, L. Bezmelnitsyna, A. Bucsics, F. Arickx, A. Bybau, T. Bochenek, M. van der Casteele, E. Diogene, I. Eriksson, J. Furst, M. Gad, I. Greičiute-Kuprijanov, M. van der Graff, J. Gulbinovic, J. Jones, R. Joppi, M. Kalaba, O. Laius, I. Langner, I. Mardare, V. Marković Peković, E. Magnusson, O. Melien, D. Meshkov, G. Petrova, G. Selke, C. Sermet, S. Simoens, A. Schuurman, R. Ramos, J. Rodrigues, C. Zara, E. Zebedin-Brandl, A. Haycox, Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation, Frontiers in Pharmacology, Vol. 8, pp. 1 - 13, Aug, 2017
Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018-01)

T. Bochenek, V. Abilova, A. Alkan, B. Asanin, I. Beriain, Z. Besovic, P. Vella Bonanno, A. Bucsics, M. Davidescu, E. de Weerdt, N. Duborija-Kovacevic, J. Furst, M. Gaga, E. Gailite, J. Gulbinovic, E. Gurpinar, B. Hanko, V. Hargaden, T. Hotvedt, I. Hoxha, I. Huys, A. Inotai, A. Jakupi, H. Jenzer, R. Joppi, O. Laius, M. Lenormand, D. Makridaki, A. Malaj, K. Margus, V. Marković Peković, N. Miljkovic, J. de Miranda, S. Primozic, D. Rajinac, D. schwartz, R. Sebesta, S. Simoens, J. Slaby, L. Sović-Brkičić, T. Tesar, L. Tzirnis, E. Warminska, B. Godman, Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries, Frontiers in Pharmacology, Vol. 8, No. article 942, pp. 1 - 23, Jan, 2018
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Care; Their Influence and Implications (2018-05)

L. Bojanić, V. Marković Peković, R. Škrbić, N. Stojaković, M. Đermanović, J. Bojanić, J. Furst, A. Kurdi, B. Godman, Recent Initiatives in the Republic of Srpska to Enhance Appropriate Care; Their Influence and Implications, Frontiers in Pharmacology, Vol. 9, No. Article 442, pp. 1 - 13, May, 2018
Are pharmacists’ good knowledge and awareness on antibiotic taken for granted ? The situation in Albania and future implications across countries (2018-06)

I. Hoxha, A. Malaj, B. Kraja, S. Bino, M. Oluka, V. Marković Peković, B. Godman, Are pharmacists’ good knowledge and awareness on antibiotic taken for granted ? The situation in Albania and future implications across countries, Journal of global antimicrobial resistance, Vol. 13, pp. 240 - 245, Jun, 2018
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets (2018-12)

B. Godman, A. Bucsics, P. Vella Bonanno, W. Oortwijn, C. Rothe, A. Ferrario, S. Bosselli, A. Hill, A. Martin, S. Simoens, A. Kurdi, M. Gad, J. Gulbinovic, A. Timoney, T. Bochenek, A. Salem, I. Hoxha, R. Sauermann, A. Massele, A. Guerra Junior, G. Petrova, Z. Mitkova, G. Achniotou, O. Laius, C. Sermet, G. Selke, V. Kourafalos, J. Yfantopoulos, E. Magnusson, R. Joppi, M. Oluka, H. Kwon, A. Jakupi, F. Kalemeera, J. Fadare, O. Melien, M. Pomorski, M. Wladysiuk, V. Marković Peković, I. Mardare, D. Meshkov, T. Novakovic, J. Furst, D. Tomek, C. Zara, E. diogene, J. Meyer, R. Malmstrom, B. Wettermark, Z. Matsebula, S. Campbell, A. Haycox, Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets, Frontiers in public health, Vol. 6, No. Article 328, pp. 1 - 21, Dec, 2018
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA (2019-02)

P. Vella Bonanno, A. Bucsics, S. Simoens, A. Martin, W. Oortwijn, J. Gulbinovic, C. Rothe, A. Timoney, A. Ferrario, M. Gad, A. Salem, I. Hoxha, R. Sauremann, M. Kamusheva, M. Dimitrova, G. Petrova, O. Laius, G. Selke, V. Kourafalos, J. Yfantopoulos, E. Magnusson, R. Joppi, A. Jakupi, T. Bochenek, M. Wladysiuk, C. Furtado, V. Marković Peković, I. Mardare, D. Meshkov, J. Furst, D. Tomek, M. Obach Cortadellas, C. Zara, A. Haycox, S. Campbell, B. Godman, Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA, Expert Review of Pharmacoeconomics & Outcome Research, Vol. 19, No. 3, pp. 251 - 261, Feb, 2019
Pricing of oral generic cancer medicines in 25 European countries; findings and implications (2019-02)

B. Godman, A. Hill, S. Simoens, A. Kurdi, J. Gulbinovic, A. Margus, A. Timoney, D. Gotham, J. Wale, T. Bochenek, I. Hoxha, C. Rodrigues, C. Hierlander, A. Malaj, R. Sauremann, W. Hamelinck, Z. Mitkova, G. Petrova, O. Laius, C. Sermet, I. Langer, G. Selke, J. Yfantopoulos, R. Joppi, A. Jakupi, E. Poplavski, I. Greičiute-Kuprijanov, P. Vella Bonanno, H. Piepenbrink, V. Valk, C. Hagen, A. Ringerud, R. Plisko, M. Wladysiuk, V. Marković Peković, N. Grubiša, T. Ponorac, I. Mardare, T. Novakovic, M. Parker, J. Fraeyman, D. Tomek, M. Obach Cortadellas, C. Zara, M. Juhasz-Haverinen, P. Skiold, S. McTaggart, A. Heycox, Pricing of oral generic cancer medicines in 25 European countries; findings and implications, Generics and Biosimilars Initiative Journal, Vol. 8, No. 2, pp. 49 - 70, Feb, 2019

Items

Potential Strategies to Limit Inappropriate Purchasing of Antibiotics without a Prescription in a Rural Province in South Africa: Pilot Study and the Implications (2024-01)

Effective Programmes to Reduce Inappropriate Dispensing of Antibiotics in Community Pharmacies Especially in Developing Countries (2024-01)

Pilot Study to Evaluate the Feasibility of a Patient Questionnaire for the Purpose of Investigating the Extent of Purchasing Antibiotics without a Prescription in a Rural Province in South Africa: Rationale and Implications (2024-03)

Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance (2023-04)

Essential to increase the use of generics in Europe to maintain comprehensive health care? (2012-01)

Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions (2012-09)

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs (2014-06)

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications (2014-06)

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future (2015-05)

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways (2016-09)

Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future (2016-10)

Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications (2017-06)

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications (2017-08)

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation (2017-08)

Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018-01)

Recent Initiatives in the Republic of Srpska to Enhance Appropriate Care; Their Influence and Implications (2018-05)

Are pharmacists’ good knowledge and awareness on antibiotic taken for granted ? The situation in Albania and future implications across countries (2018-06)

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets (2018-12)

Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA (2019-02)

Pricing of oral generic cancer medicines in 25 European countries; findings and implications (2019-02)